Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

ClinicalTrials.gov ID: NCT03428217

Public ClinicalTrials.gov record NCT03428217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Tthe primary objective of this study is to compare blinded Independent Radiology Committee (IRC)-adjudicated progression free survival (PFS) of patients treated with CB-839 + cabozantinib (CB-Cabo) versus placebo + cabozantinib (Pbo-Cabo) for advanced or metastatic clear-cell RCC (ccRCC).

Study identification

NCT ID
NCT03428217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Calithera Biosciences, Inc
Industry
Enrollment
444 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 24, 2018 (Actual)
Primary completion
Aug 31, 2020 (Actual)
Completion
Jul 16, 2021 (Actual)
Last update posted
Mar 20, 2023

2018 – 2021

United States locations

U.S. sites
59
U.S. states
29
U.S. cities
54
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Mayo Clinic Cancer Center Phoenix Arizona 85054 —
The University of Arizona Cancer Center Tucson Arizona 85724 —
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 —
Stanford Cancer Center Palo Alto California 94304 —
Salinas Valley Memorial Healthcare System Salinas California 93901 —
St. Joseph Heritage Healthcare Santa Rosa California 95403 —
Penrose Cancer Center, Research Department Colorado Springs Colorado 80907 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Florida Cancer Specialists Fort Myers Florida 33901 —
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
H.Lee Moffitt Cancer & Research Institute (Moffitt Cancer Center) Tampa Florida 33612 —
Emory Winship Cancer Institute Atlanta Georgia 30322 —
Georgia Cancer Center at Augusta University Augusta Georgia 30912 —
Northwest Georgia Oncology Centers, PC Marietta Georgia 30060 —
St. Luke's Mountain States Tumor Institute Boise Idaho 83712 —
Northwestern University Chicago Illinois 60611 —
University of Chicago Chicago Illinois 60637 —
NorthShore University HealthSystem Evanston Illinois 60201 —
AMITA Health Cancer Institute & Outpatient Center Hinsdale Illinois 60521 —
Orchard Healthcare Research, Inc. Skokie Illinois 60077 —
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555 —
Goshen Center for Cancer Care Goshen Indiana 46526 —
East Jefferson General Hospital Metairie Louisiana 70006 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Karmanos Cancer Institute Detroit Michigan 48201 —
HealthPartners Institute, Regions Cancer Care Center Saint Paul Minnesota 55101 —
Hattiesburg Clinic Hematology/Oncology Hattiesburg Mississippi 39401 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Mercy Hospital Joplin Missouri 64804 —
HCA Midwest Health Kansas City Missouri 64132 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148 —
San Juan Oncology Associates, PC Farmington New Mexico 87401 —
Roswell Park Cancer Center Buffalo New York 14263 —
North Shore Hematology Oncology Associates PC dba NY Cancer and Blood Specialists East Setauket New York 11733 —
NYU Winthrop Hospital Mineola New York 11501 —
Northern Westchester Hospital Mount Kisco New York 10549 —
Stony Brook Cancer Center Stony Brook New York 11794 —
Levine Cancer Institute Charlotte North Carolina 28204 —
Duke University Medical Center Durham North Carolina 27710 —
INTEGRIS Cancer Institute of Oklahoma Proton Campus Oklahoma City Oklahoma 73142 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
Medical University of South Carolina Charleston South Carolina 29425 —
Saint Francis Hospital Cancer Center Greenville South Carolina 29607 —
West Cancer Center Germantown Tennessee 38138 —
The Sarah Cannon Research Institute Nashville Tennessee 37203 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
University of Utah, Huntsman Cancer Institute Salt Lake City Utah 84112 —
Kadlec Clinic Hematology and Oncology Kennewick Washington 99336 —
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03428217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2023 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03428217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →